GSK to shut down UK antibiotic facility following end of Sandoz contract
GSK is closing down a facility and is winding down antibiotic manufacturing operations at another factory as Novartis’ Sandoz chooses to end its four-year contract. The British drugmaker will close down antibiotic operations at its facility in Ulverston, a town in the North of the UK, in June 2025 and